Charles River Laboratories International, Inc.CRLNYSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank57
3Y CAGR-2.9%
5Y CAGR-2.9%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-2.9%/yr
vs +2.6%/yr prior
5Y CAGR
-2.9%/yr
Consistent
Acceleration
-5.5pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 22.69% | +58.1% |
| 2024 | 14.35% | -42.6% |
| 2023 | 24.99% | +0.8% |
| 2022 | 24.80% | +7.1% |
| 2021 | 23.17% | -11.9% |
| 2020 | 26.28% | +22.4% |
| 2019 | 21.48% | -4.0% |
| 2018 | 22.38% | -9.2% |
| 2017 | 24.65% | +9.9% |
| 2016 | 22.44% | - |